Does VELAGLUCERASE ALFA Cause Product dose omission issue? 188 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Product dose omission issue have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 10.8% of all adverse event reports for VELAGLUCERASE ALFA.
188
Reports of Product dose omission issue with VELAGLUCERASE ALFA
10.8%
of all VELAGLUCERASE ALFA reports
15
Deaths
83
Hospitalizations
How Dangerous Is Product dose omission issue From VELAGLUCERASE ALFA?
Of the 188 reports, 15 (8.0%) resulted in death, 83 (44.1%) required hospitalization, and 6 (3.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 188 reports have been filed with the FAERS database.
What Other Side Effects Does VELAGLUCERASE ALFA Cause?
Inappropriate schedule of product administration (197)
Covid-19 (163)
Fatigue (136)
Death (108)
Fall (104)
Pyrexia (101)
Malaise (98)
Weight increased (89)
Headache (88)
Arthralgia (84)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VELAGLUCERASE ALFA Alternatives Have Lower Product dose omission issue Risk?
VELAGLUCERASE ALFA vs VELCADE
VELAGLUCERASE ALFA vs VELETRI
VELAGLUCERASE ALFA vs VELIPARIB
VELAGLUCERASE ALFA vs VEMURAFENIB
VELAGLUCERASE ALFA vs VENETOCLAX